In-Vitro Colorectal Cancer Screening Tests Market 2027 By Type, Service Provider, and Geography | The Insight Partners

In-Vitro Colorectal Cancer Screening Tests Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Fecal Occult Blood Test, Biomarker Test, Flexible Sigmoidoscopy, Others); Service Provider (Hospitals, Cancer Centers, Diagnostics Laboratories), and Geography

Report Code: TIPRE00016655 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

The development of diagnostics has launched various technologies to screen and diagnose colorectal cancer. The recent technique that is widely used to detect colorectal cancer is the immunochemistry test. It includes two major tests, such as a fecal occult test and a biomarker test. These tests help prevent the mortality numbers up 20% by detecting colorectal cancer at the biennial stage.

MARKET DYNAMICS

The in-vitro colorectal cancer screening tests market growth is estimated due to growing contract manufacturing, increased biotechnology research, and increasing incidences of chronic diseases leading to clinical diagnostics. The growing in vitro diagnostics in developing regions is expected to create vital growth opportunities for market growth.

MARKET SCOPE

The "In-Vitro Colorectal Cancer Screening Tests Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in-vitro colorectal cancer screening tests market with detailed market segmentation by type, and service provider. The in-vitro colorectal cancer screening tests market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in in-vitro colorectal cancer screening tests market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The in-vitro colorectal cancer screening tests market is segmented on the basis of, type, and service provider. Based on type, the market is divided into fecal occult blood test, biomarker test, flexible sigmoidoscopy, and others. And based on service provider, the market is classified as hospitals, cancer centers, and diagnostics laboratories.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in-vitro colorectal cancer screening tests market based on various segments. It also provides market size and forecast estimates from year 2019 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The in-vitro colorectal cancer screening tests market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting in-vitro colorectal cancer screening tests market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the in-vitro colorectal cancer screening tests market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in-vitro colorectal cancer screening tests market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in-vitro colorectal cancer screening tests market are anticipated to have lucrative growth opportunities in the future with the rising demand for in-vitro colorectal cancer screening tests in the global market. Below mentioned is the list of few companies engaged in the in-vitro colorectal cancer screening tests market.

The report also includes the profiles of key players in in-vitro colorectal cancer screening tests market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Abbott
  •  F. Hoffmann-La Roche AG
  •  Quest Diagnostics
  •  Sysmex Corporation
  •  Siemens Healthcare
  •  Alere Inc.
  •  Eiken Chemical
  •  Siemens AG
  •  OncoCyte Corporation-Biotime
  •  Merck KGaA

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 In-Vitro Colorectal Cancer Screening Tests Market - By Type
1.3.2 In-Vitro Colorectal Cancer Screening Tests Market - By Service Provider
1.3.3 In-Vitro Colorectal Cancer Screening Tests Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. IN-VITRO COLORECTAL CANCER SCREENING TESTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. IN-VITRO COLORECTAL CANCER SCREENING TESTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. IN-VITRO COLORECTAL CANCER SCREENING TESTS MARKET - GLOBAL MARKET ANALYSIS
6.1. IN-VITRO COLORECTAL CANCER SCREENING TESTS - GLOBAL MARKET OVERVIEW
6.2. IN-VITRO COLORECTAL CANCER SCREENING TESTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. IN-VITRO COLORECTAL CANCER SCREENING TESTS MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. FECAL OCCULT BLOOD TEST
7.3.1. Overview
7.3.2. Fecal Occult Blood Test Market Forecast and Analysis
7.3.3. Guaiac FOB Stool Test Market
7.3.3.1. Overview
7.3.3.2. Guaiac FOB Stool Test Market Forecast and Analysis
7.3.4. Immuno-FOB Agglutination Test Market
7.3.4.1. Overview
7.3.4.2. Immuno-FOB Agglutination Test Market Forecast and Analysis
7.3.5. Lateral Flow Immuno-FOB Test Market
7.3.5.1. Overview
7.3.5.2. Lateral Flow Immuno-FOB Test Market Forecast and Analysis
7.3.6. Immuno-FOB ELISA Test Market
7.3.6.1. Overview
7.3.6.2. Immuno-FOB ELISA Test Market Forecast and Analysis
7.4. BIOMARKER TEST
7.4.1. Overview
7.4.2. Biomarker Test Market Forecast and Analysis
7.4.3. Tumor M2-PK Stool Test Market
7.4.3.1. Overview
7.4.3.2. Tumor M2-PK Stool Test Market Forecast and Analysis
7.4.4. Methylated Gene Test Market
7.4.4.1. Overview
7.4.4.2. Methylated Gene Test Market Forecast and Analysis
7.4.5. Panel DNA Test Market
7.4.5.1. Overview
7.4.5.2. Panel DNA Test Market Forecast and Analysis
7.5. FLEXIBLE SIGMOIDOSCOPY
7.5.1. Overview
7.5.2. Flexible Sigmoidoscopy Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. IN-VITRO COLORECTAL CANCER SCREENING TESTS MARKET - REVENUE AND FORECASTS TO 2027 - SERVICE PROVIDER
8.1. OVERVIEW
8.2. SERVICE PROVIDER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CANCER CENTERS
8.4.1. Overview
8.4.2. Cancer Centers Market Forecast and Analysis
8.5. DIAGNOSTICS LABORATORIES
8.5.1. Overview
8.5.2. Diagnostics Laboratories Market Forecast and Analysis
9. IN-VITRO COLORECTAL CANCER SCREENING TESTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America In-Vitro Colorectal Cancer Screening Tests Market Overview
9.1.2 North America In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis
9.1.3 North America In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Type
9.1.4 North America In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Service Provider
9.1.5 North America In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Countries
9.1.5.1 United States In-Vitro Colorectal Cancer Screening Tests Market
9.1.5.1.1 United States In-Vitro Colorectal Cancer Screening Tests Market by Type
9.1.5.1.2 United States In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.1.5.2 Canada In-Vitro Colorectal Cancer Screening Tests Market
9.1.5.2.1 Canada In-Vitro Colorectal Cancer Screening Tests Market by Type
9.1.5.2.2 Canada In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.1.5.3 Mexico In-Vitro Colorectal Cancer Screening Tests Market
9.1.5.3.1 Mexico In-Vitro Colorectal Cancer Screening Tests Market by Type
9.1.5.3.2 Mexico In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.2. EUROPE
9.2.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Overview
9.2.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis
9.2.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Type
9.2.4 Europe In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Service Provider
9.2.5 Europe In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Countries
9.2.5.1 Germany In-Vitro Colorectal Cancer Screening Tests Market
9.2.5.1.1 Germany In-Vitro Colorectal Cancer Screening Tests Market by Type
9.2.5.1.2 Germany In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.2.5.2 France In-Vitro Colorectal Cancer Screening Tests Market
9.2.5.2.1 France In-Vitro Colorectal Cancer Screening Tests Market by Type
9.2.5.2.2 France In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.2.5.3 Italy In-Vitro Colorectal Cancer Screening Tests Market
9.2.5.3.1 Italy In-Vitro Colorectal Cancer Screening Tests Market by Type
9.2.5.3.2 Italy In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.2.5.4 Spain In-Vitro Colorectal Cancer Screening Tests Market
9.2.5.4.1 Spain In-Vitro Colorectal Cancer Screening Tests Market by Type
9.2.5.4.2 Spain In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.2.5.5 United Kingdom In-Vitro Colorectal Cancer Screening Tests Market
9.2.5.5.1 United Kingdom In-Vitro Colorectal Cancer Screening Tests Market by Type
9.2.5.5.2 United Kingdom In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.2.5.6 Rest of Europe In-Vitro Colorectal Cancer Screening Tests Market
9.2.5.6.1 Rest of Europe In-Vitro Colorectal Cancer Screening Tests Market by Type
9.2.5.6.2 Rest of Europe In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Overview
9.3.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis
9.3.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Service Provider
9.3.5 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Countries
9.3.5.1 Australia In-Vitro Colorectal Cancer Screening Tests Market
9.3.5.1.1 Australia In-Vitro Colorectal Cancer Screening Tests Market by Type
9.3.5.1.2 Australia In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.3.5.2 China In-Vitro Colorectal Cancer Screening Tests Market
9.3.5.2.1 China In-Vitro Colorectal Cancer Screening Tests Market by Type
9.3.5.2.2 China In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.3.5.3 India In-Vitro Colorectal Cancer Screening Tests Market
9.3.5.3.1 India In-Vitro Colorectal Cancer Screening Tests Market by Type
9.3.5.3.2 India In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.3.5.4 Japan In-Vitro Colorectal Cancer Screening Tests Market
9.3.5.4.1 Japan In-Vitro Colorectal Cancer Screening Tests Market by Type
9.3.5.4.2 Japan In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.3.5.5 South Korea In-Vitro Colorectal Cancer Screening Tests Market
9.3.5.5.1 South Korea In-Vitro Colorectal Cancer Screening Tests Market by Type
9.3.5.5.2 South Korea In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.3.5.6 Rest of Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market
9.3.5.6.1 Rest of Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market by Type
9.3.5.6.2 Rest of Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Overview
9.4.2 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis
9.4.3 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Service Provider
9.4.5 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa In-Vitro Colorectal Cancer Screening Tests Market
9.4.5.1.1 South Africa In-Vitro Colorectal Cancer Screening Tests Market by Type
9.4.5.1.2 South Africa In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.4.5.2 Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Market
9.4.5.2.1 Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Market by Type
9.4.5.2.2 Saudi Arabia In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.4.5.3 U.A.E In-Vitro Colorectal Cancer Screening Tests Market
9.4.5.3.1 U.A.E In-Vitro Colorectal Cancer Screening Tests Market by Type
9.4.5.3.2 U.A.E In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.4.5.4 Rest of Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market
9.4.5.4.1 Rest of Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market by Type
9.4.5.4.2 Rest of Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America In-Vitro Colorectal Cancer Screening Tests Market Overview
9.5.2 South and Central America In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis
9.5.3 South and Central America In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Type
9.5.4 South and Central America In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Service Provider
9.5.5 South and Central America In-Vitro Colorectal Cancer Screening Tests Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil In-Vitro Colorectal Cancer Screening Tests Market
9.5.5.1.1 Brazil In-Vitro Colorectal Cancer Screening Tests Market by Type
9.5.5.1.2 Brazil In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.5.5.2 Argentina In-Vitro Colorectal Cancer Screening Tests Market
9.5.5.2.1 Argentina In-Vitro Colorectal Cancer Screening Tests Market by Type
9.5.5.2.2 Argentina In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
9.5.5.3 Rest of South and Central America In-Vitro Colorectal Cancer Screening Tests Market
9.5.5.3.1 Rest of South and Central America In-Vitro Colorectal Cancer Screening Tests Market by Type
9.5.5.3.2 Rest of South and Central America In-Vitro Colorectal Cancer Screening Tests Market by Service Provider
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL IN-VITRO COLORECTAL CANCER SCREENING TESTS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. IN-VITRO COLORECTAL CANCER SCREENING TESTS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. F. HOFFMANN-LA ROCHE AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. QUEST DIAGNOSTICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. SYSMEX CORPORATION
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SIEMENS HEALTHCARE
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ALERE INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. EIKEN CHEMICAL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SIEMENS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ONCOCYTE CORPORATION-BIOTIME
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MERCK KGAA
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott
2. F. Hoffmann-La Roche AG
3. Quest Diagnostics
4. Sysmex Corporation
5. Siemens Healthcare
6. Alere Inc.
7. Eiken Chemical
8. Siemens AG
9. OncoCyte Corporation-Biotime
10. Merck KGaA
TIPRE00016655
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking